Derivation of induced pluripotent stem cells line (RCPCMi007-A-1) with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9 genome editing

Summary

The mismatch of HLA haplotypes between donor and recipient adversely affects the outcome of tissue transplantation. TheB2Mgene knockout (B2M-KO) disrupts the HLA I heterodimer formation; therefore,B2M-KO cells have reduced immunogenicity to allogeneic CD8+ T cells. Thus, theB2M-KO IPSCs and their derivatives can potentially solve a problem of the immunological compatibility in allogeneic transplantations. Using CRISPR/Cas9-mediated genome editing, we generated a human B2M-KO iPSC line (RCPCMi007-A-1). The RCPCMi007-A-1 iPSCs express pluripotency markers, have typical stem cell morphology, maintain normal karyotype, and the ability to differentiate into three germ layers. Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Authors Bogomiakova ME, Sekretova EK, Eremeev AV, Shuvalova LD, Bobrovsky PA, Zerkalenkova EA, Lebedeva OS, Lagarkova MA
Journal Stem cell research
Publication Date 2021 Aug;55:102451
PubMed 34237591
DOI 10.1016/j.scr.2021.102451

Research Projects

Cell Lines